Neuroacanthocytosis with unusual clinical features: A case report.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
Jan 2019
Historique:
entrez: 12 1 2019
pubmed: 12 1 2019
medline: 23 1 2019
Statut: ppublish

Résumé

Neuroacanthocytosis (NA) is a heterogeneous group of inherited neurodegenerative disorders characterized by misshapen spiculated erythorcytes and symptoms that resemble Huntington's disease. A 59-year-old female who developed hyperkinetic involuntary movements that became progressively more obvious during the course of a year. Acanthocytes were observed in a peripheral blood smear. The patient had elevated levels of serum creatine kinase (CK). Gene sequencing did not reveal a genetic mutation. The patient was administered oral tiapride, alprazolam, B1 and B12 Vitamins. After 2 months of treatment the patient's symptoms were obviously alleviated. At the 6 month follow-up, the patient could feed herself and walk without assistance. The NA syndrome is extremely rare. It may be identified in the clinic based on abnormal orofacial movement, chorea, cognitive decline, elevated CK levels, and acanthocytosis. If available, protein- or genetic-based testing may provide a confirmatory diagnosis.

Identifiants

pubmed: 30633203
doi: 10.1097/MD.0000000000014050
pii: 00005792-201901110-00054
pmc: PMC6336636
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14050

Références

Neurology. 2006 Sep 26;67(6):940-3
pubmed: 17000958
Mov Disord. 2006 Oct;21(10):1728-31
pubmed: 16874760
Tremor Other Hyperkinet Mov (N Y). 2014 Oct 31;4:248
pubmed: 25374764
J Neurol Sci. 2005 Mar 15;229-230:171-86
pubmed: 15760637
Acta Neuropathol. 2010 Feb;119(2):271-3
pubmed: 19949804
Neurology. 2014 Feb 25;82(8):e70
pubmed: 24566231
Singapore Med J. 1989 Oct;30(5):506-8
pubmed: 2617308
PLoS One. 2015 Apr 27;10(4):e0125861
pubmed: 25915509
J Neurol Sci. 2014 May 15;340(1-2):221-4
pubmed: 24635891
J Mov Disord. 2015 May;8(2):41-54
pubmed: 26090076
Neurology. 2007 Jan 9;68(2):92-8
pubmed: 17210889
Clin Neurol Neurosurg. 2016 Aug;147:78-83
pubmed: 27310290
Mov Disord. 2008 Oct 30;23(14):2090-3
pubmed: 18785241
Mov Disord. 2010 Jan 15;25(1):127-9
pubmed: 19938148
Acta Neuropathol. 2014 Apr;127(4):613-5
pubmed: 24394886
Orphanet J Rare Dis. 2011 Oct 25;6:68
pubmed: 22027213
Nat Genet. 2001 Jun;28(2):121-2
pubmed: 11381254

Auteurs

Hui Zhu (H)

Department of Neurology, The First Hospital, Jilin University, Changchun, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH